InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Nandabalan Krishnan, 董事. Insider active across 1 company, notably BioXcel Therapeutics, Inc.. Cumulatively, 4 reports have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €12.2m. Activity tracked since 25 June 2021. The latest transaction was filed on 6 April 2023 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Nandabalan Krishnan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报4 总计
60,000 股@ US$0.410.1% 占其流量Common StockSEC:0001104659-23-043694:0
34,111 股@ US$0.410.1% 占其流量Common StockSEC:0001104659-23-001945:0
27,450 股@ US$0.410.0% 占其流量Common StockSEC:0001104659-22-118836:0
473,250 股@ US$30.828399.6% 占其流量Common StockSEC:0001104659-21-086946:0
4 条申报中的 4 条
About Nandabalan Krishnan
Krishnan Nandabalan is a Board Member of BioXcel Therapeutics, Inc. He brings expertise in corporate strategy and governance. His role on the board allows him to actively participate in strategic decision-making for the company. Through his experience, he helps guide growth initiatives and strengthen BioXcel's market position.
